Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions

eLife

Volumn 5, Issue MARCH2016, 2016, Pages

  Villarino, Alejandro ^a   Laurence, Arian ^a   Robinson, Gertraud W ^a   Bonelli, Michael ^a   Dema, Barbara ^a   Afzali, Behdad ^a   Shih, Han Yu ^a   Sun, Hong Wei ^a   Brooks, Stephen R ^a   Hennighausen, Lothar ^a   Kanno, Yuka ^a   O’Shea, John J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; STAT5A PROTEIN, MOUSE; STAT5B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EFFECTOR CELL; ERYTHROCYTE; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HISTOLOGY; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; MICE, INBRED C57BL; MICE, KNOCKOUT; STAT5 TRANSCRIPTION FACTOR;

EID: 84969240482     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08384     Document Type: Article

References (79)

1. Ballesteros-Tato A, León B, Graf BA, Moquin A, Adams PS, Lund FE, Randall TD. 2012. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Elsevier Inc 36:847–856. doi: 10.1016/j.immuni.2012.02.012
2. Bible PW, Kanno Y, Wei L, Brooks SR, O’Shea JJ, Morasso MI, Loganantharaj R, Sun HW. 2015. PAPST, a user friendly and powerful Java platform for chIP-seq peak co-localization analysis and beyond. PloS One 10: e0127285. doi: 10.1371/journal.pone.0127285
3. Boucheron C, Dumon S, Santos SC, Moriggl R, Hennighausen L, Gisselbrecht S, Gouilleux F. 1998. A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities. The Journal of Biological Chemistry 273:33936–33941. doi: 10.1074/jbc.273.51.33936
4. Brewster RC, Weinert FM, Garcia HG, Song D, Rydenfelt M, Phillips R. 2014. The transcription factor titration effect dictates level of gene expression. Cell 156:1312–1323. doi: 10.1016/j.cell.2014.02.022
5. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. 2007. IL-2 receptor-dependent STAT5 activation is required for the development of foxp3+ regulatory T cells. The Journal of Immunology 178:280–290. doi: 10.4049/jimmunol.178.1.280
6. Caldenhoven E, van Dijk TB, Tijmensen A, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. 1998. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells. Stem Cells 16:397–403. doi: 10.1002/stem.160397
7. Cohen AC, Nadeau KC, Tu W, Hwa V, Dionis K, Bezrodnik L, Teper A, Gaillard M, Heinrich J, Krensky AM, Rosenfeld RG, Lewis DB. 2006. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25 (high) T cells in human STAT5b deficiency. Journal of Immunology 177:2770–2774. doi: 10.4049/jimmunol.177.5.2770
8. Crotty S. 2011. Follicular helper CD4 T cells (TFH). Annual Review of Immunology 29:621–663. doi: 10.1146/annurev-immunol-031210-101400
9. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson GW, Hennighausen L. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Molecular and Cellular Biology 24:8037–8047. doi: 10.1128/MCB.24.18.8037-8047.2004
10. Dooms H, Wolslegel K, Lin P, Abbas AK. 2007. Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. Journal of Experimental Medicine 204:547–557. doi: 10.1084/jem.20062381
11. Editorial. 2014. Kick the bar chart habit. Nature Methods 11:113. doi: 10.1038/nmeth.2837
12. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, Bucher P. 2001. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. Journal of Biological Chemistry 276:6675–6688. doi: 10.1074/jbc.M001748200
13. Esashi E, Wang YH, Perng O, Qin XF, Liu YJ, Watowich SS. 2008. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28:509–520. doi: 10.1016/j.immuni.2008.02.013
14. Feng J, Liu T, Qin B, Zhang Y, Liu XS. 2012. Identifying ChIP-seq enrichment using MACS. Nature Protocols 7: 1728–1740. doi: 10.1038/nprot.2012.101
15. Garber M, Grabherr MG, Guttman M, Trapnell C. 2011. Computational methods for transcriptome annotation and quantification using RNA-seq. Nature Methods 8:469–477. doi: 10.1038/nmeth.1613
16. Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno ED, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, et al. 2012. The cytokines interleukin 27 and interferon-g promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37:511–523. doi: 10.1016/j.immuni.2012.06.014
17. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular Cell 38:576–589. doi: 10.1016/j.molcel.2010.05.004
18. Hennighausen L, Robinson GW. 2008. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes & Development 22:711–721. doi: 10.1101/gad.1643908
19. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. 2007. Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786–800. doi: 10.1016/j.immuni.2007.09.010
20. Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y, Beug H, Hennighausen L, Moriggl R, Sexl V. 2006. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 107:4898–4906. doi: 10.1182/blood-2005-09-3596
21. Imada K, Bloom ET, Nakajima H, Horvath-Arcidiacono JA, Udy GB, Davey HW, Leonard WJ. 1998. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. The Journal of Experimental Medicine 188:2067–2074. doi: 10.1084/jem.188.11.2067
22. Jenks JA, Seki S, Kanai T, Huang J, Morgan AA, Scalco RC, Nath R, Bucayu R, Wit JM, Al-Herz W, Ramadan D, Jorge AA, Bacchetta R, Hwa V, Rosenfeld R, Nadeau KC. 2013. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clinical Immunology 148:227–236. doi: 10.1016/j.clim.2013.04.014
23. Johnston RJ, Choi YS, Diamond JA, Yang JA, Crotty S. 2012. STAT5 is a potent negative regulator of TFH cell differentiation. Journal of Experimental Medicine 209:243–250. doi: 10.1084/jem.20111174
24. Kagami S, Nakajima H, Kumano K, Suzuki K, Suto A, Imada K, Davey HW, Saito Y, Takatsu K, Leonard WJ, Iwamoto I. 2000. Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95:1370–1377.
25. Kagami S, Nakajima H, Suto A, Hirose K, Suzuki K, Morita S, Kato I, Saito Y, Kitamura T, Iwamoto I. 2001. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97:2358–2365. doi: 10.1182/blood.V97.8.2358
26. Kanai T, Jenks J, Nadeau KC. 2012. The STAT5b pathway defect and autoimmunity. Frontiers in Immunology 3: 234. doi: 10.3389/fimmu.2012.00234
27. Kanai T, Seki S, Jenks JA, Kohli A, Kawli T, Martin DP, Snyder M, Bacchetta R, Nadeau KC. 2014. Identification of STAT5A and STAT5B target genes in human T cells. PloS One 9:e86790. doi: 10.1371/journal.pone.0086790
28. Kelly J, Spolski R, Imada K, Bollenbacher J, Lee S, Leonard WJ. 2003a. A role for stat5 in CD8+ T cell homeostasis. Journal of Immunology 170:210–217. doi: 10.4049/jimmunol.170.1.210
29. Kelly JA, Spolski R, Kovanen PE, Suzuki T, Bollenbacher J, Pise-Masison CA, Radonovich MF, Lee S, Jenkins NA, Copeland NG, Morse HC, Leonard WJ. 2003b. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. Journal of Experimental Medicine 198:79–89. doi: 10.1084/jem.20021548
30. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunology 10: 595–602. doi: 10.1038/ni.1731
31. Koch MA, Thomas KR, Perdue NR, Smigiel KS, Srivastava S, Campbell DJ. 2012. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor b2. Immunity 37:501–510. doi: 10.1016/j.immuni.2012.05.031
32. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Research 19:1639–1645. doi: 10.1101/gr.092759.109
33. Kuhrt D, Wojchowski DM. 2015. Emerging EPO and EPO receptor regulators and signal transducers. Blood 125. doi: 10.1182/blood-2014-11-575357
34. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 10:R25. doi: 10.1186/gb-2009-10-3-r25
35. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O’shea JJ. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371–381. doi: 10.1016/j.immuni.2007.02.009
36. Lenardo MJ. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858–861. doi: 10.1038/353858a0
37. Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY, Zhao K, Leonard WJ. 2008. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nature Immunology 9:1288–1296. doi: 10.1038/ni.1656
38. Liao W, Lin JX, Wang L, Li P, Leonard WJ. 2011. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nature Immunology 12:551–559. doi: 10.1038/ni.2030
39. Liao W, Spolski R, Li P, Du N, West EE, Ren M, Mitra S, Leonard WJ. 2014. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proceedings of the National Academy of Sciences of the United States of America 111:3508–3513. doi: 10.1073/pnas.1301138111
40. Liongue C, O’Sullivan LA, Trengove MC, Ward AC. 2012. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development. PloS One 7:e32777. doi: 10.1371/journal.pone.0032777
41. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L. 1995. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proceedings of the National Academy of Sciences of the United States of America 92:8831–8835. doi: 10.1073/pnas.92.19.8831
42. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes & Development 11:179–186. doi: 10.1101/gad.11.2.179
43. Lohse M, Bolger AM, Nagel A, Fernie AR, Lunn JE, Stitt M, Usadel B. 2012. RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Research 40:W622–627. doi: 10.1093/nar/gks540
44. Mahmud SA, Manlove LS, Farrar MA. 2013. Interleukin-2 and STAT5 in regulatory T cell development and function. JAK-STAT 2:e23154. doi: 10.4161/jkst.23154
45. Malek TR, CastroI Thomas R. 2010. Interleukin-2 receptor signaling: At the interface between tolerance and immunity. Immunity 33:153–165. doi: 10.1016/j.immuni.2010.08.004
46. Meinke A, Barahmand-Pour F, Wöhrl S, Stoiber D, Decker T. 1996. Activation of different stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Molecular and Cellular Biology 16:6937–6944. doi: 10.1128/MCB.16.12.6937
47. Metser G, Shin HY, Wang C, Yoo KH, Oh S, Villarino AV, O’Shea JJ, Kang K, Hennighausen L. 2016. An autoregulatory enhancer controls mammary-specific STAT5 functions. Nucleic Acids Research 44:1052–1063. doi: 10.1093/nar/gkv999
48. Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC, Ihle JN. 1999. Stat5 is required for il-2-induced cell cycle progression of peripheral T cells. Immunity 10:249–259. doi: 10.1016/S1074-7613(00)80025-4
49. Moriggl R, Sexl V, Piekorz R, Topham D, Ihle JN. 1999. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11:225–230. doi: 10.1016/S1074-7613(00)80097-7
50. Nivarthi H, Prchal-Murphy M, Swoboda A, Hager M, Schlederer M, Kenner L, Tuckermann J, Sexl V, Moriggl R, Ermakova O. 2015. Stat5 gene dosage in T cells modulates CD8+ T-cell homeostasis and attenuates contact hypersensitivity response in mice. Allergy 70. doi: 10.1111/all.12535
51. Oestreich KJ, Mohn SE, Weinmann AS. 2012. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nature Immunology 13:405–411. doi: 10.1038/ni.2242
52. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nature Immunology 8:1353–1362. doi: 10.1038/ni1536
53. Ramírez F, Dündar F, Diehl S, Grüning BA, Manke T. 2014. DeepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Research 42:W187–191. doi: 10.1093/nar/gku365
54. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140. doi: 10.1093/bioinformatics/btp616
55. Rochman Y, Spolski R, Leonard WJ. 2009. New insights into the regulation of T cells by gamma(c) family cytokines. Nature Reviews. Immunology 9:480–490. doi: 10.1038/nri2580
56. Rosen RL, Winestock KD, Chen G, Liu X, Hennighausen L, Finbloom DS. 1996. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes. Blood 88:1206–1214.
57. Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. 2003. Loss of tolerance and autoimmunity affecting multiple organs in stat5a/5b-deficient mice. The Journal of Immunology 171:5042–5050. doi: 10.4049/jimmunol.171.10.5042
58. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. 1999. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98:181–191. doi: 10.1016/S0092-8674(00)81013-2
59. Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, Leonard WJ. 2000. DNA binding site selection of dimeric and tetrameric stat5 proteins reveals a large repertoire of divergent tetrameric stat5a binding sites. Molecular and Cellular Biology 20:389–401. doi: 10.1128/MCB.20.1.389-401.2000
60. Stark GR, Darnell JE. 2012. The JAK-STAT pathway at twenty. Immunity 36:503–514. doi: 10.1016/j.immuni.2012.03.013
61. Van der Laan MJ, Jewell NP. 2003. Current status and right-censored data structures when observing a marker at the censoring time. Annals of Statistics 31. doi: 10.1901/jaba.2003.31-512
62. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102:15545–15550. doi: 10.1073/pnas.0506580102
63. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN. 1998. Stat5a and stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841–850. doi: 10.1016/S0092-8674(00)81444-0
64. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proceedings of the National Academy of Sciences of the United States of America 94:7239–7244. doi: 10.1073/pnas.94.14.7239
65. Villarino AV, Tato CM, Stumhofer JS, Yao Z, Cui YK, Hennighausen L, O’Shea JJ, Hunter CA. 2007. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. Journal of Experimental Medicine 204:65–71. doi: 10.1084/jem.20061198
66. Villarino AV, Kanno Y, Ferdinand JR, O’Shea JJ. 2015. Mechanisms of Jak/STAT signaling in Immunity and disease. Journal of Immunology 194:21–27. doi: 10.4049/jimmunol.1401867
67. Wang Y, Levy DE. 2012. Comparative evolutionary genomics of the STAT family of transcription factors. JAKSTAT 1:23–33. doi: 10.4161/jkst.19418
68. Warden CD, Yuan Y-C, Wu X. 2013. Optimal calculation of RNA-Seq fold-change values. International Journal of Computational Bioinformatics and in Silico Modeling 10.
69. Yamaji D, Kang K, Robinson GW, Hennighausen L. 2013. Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. Nucleic Acids Research 41:1622–1636. doi: 10.1093/nar/gks1310
70. Yamaoka K, Min B, Zhou YJ, Paul WE, O’shea JJ. 2005. Jak3 negatively regulates dendritic-cell cytokine production and survival. Blood 106:3227–3233. doi: 10.1182/blood-2005-02-0769
71. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD, Li D, Durum SK, Jiang Q, Bhandoola A, Hennighausen L, O’Shea JJ. 2006. Stat5a/b are essential for normal lymphoid development and differentiation. Proceedings of the National Academy of Sciences of the United States of America 103:1000–1005. doi: 10.1073/pnas.0507350103
72. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, Laurence A, Robinson GW, Shevach EM, Moriggl R, Hennighausen L, Wu C, O’Shea JJ. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109:4368–4375. doi: 10.1182/blood-2006-11-055756
73. Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, Shen Y, Pervouchine DD, Djebali S, Thurman RE, Kaul R, Rynes E, Kirilusha A, Marinov GK, Williams BA, Trout D, et al. 2014. A comparative encyclopedia of DNA elements in the mouse genome. Nature 515:355–364. doi: 10.1038/nature13992
74. Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE. 2000. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. The Journal of Experimental Medicine 192:719–728. doi: 10.1084/jem.192.5.719
75. Zhang Q, Wang HY, Liu X, Wasik MA. 2007. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nature Medicine 13:1341–1348. doi: 10.1038/nm1659
76. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biology 9:R137. doi: 10.1186/gb-2008-9-9-r137
77. Zhang Y, Laz EV, Waxman DJ. 2012. Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver. Molecular and Cellular Biology 32:880–896. doi: 10.1128/MCB.06312-11
78. Zhu J, Cote-Sierra J, Guo L, Paul WE. 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19:739–748. doi: 10.1016/S1074-7613(03)00292-9
79. Zhu BM, Kang K, Yu JH, Chen W, Smith HE, Lee D, Sun HW, Wei L, Hennighausen L. 2012. Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes. Nucleic Acids Research 40:4461–4472. doi: 10.1093/nar/gks056